The Endocannabinoid System of Animals
Chief Medical Officer, RxVitamins, Niwot, CO 80544-0590, USA
Received: 12 August 2019
Revised: 5 September 2019
Accepted: 6 September 2019
Published: 16 September 2019
Our understanding of the Endocannabinoid System of animals, and its ubiquitous presence in nearly all members of Animalia, has opened the door to novel approaches targeting pain management, cancer therapeutics, modulation of neurologic disorders, stress reduction, anxiety management, and inflammatory diseases. Both endogenous and exogenous endocannabinoid-related molecules are able to function as direct ligands or, otherwise, influence the EndoCannabinoid System (ECS). This review article introduces the reader to the ECS in animals, and documents its potential as a source for emerging therapeutics.